共 89 条
[1]
Hesslewood SR(1997)Frequency of adverse reactions to radiopharmaceuticals in Europe Eur J Nucl Med 24 1179-1182
[2]
Keeling DH(2014)Prevalence of adverse events to radiopharmaceuticals from 2007 to 2011 J Nucl Med 55 1308-1310
[3]
Silberstein EB(1996)Enquête prospective sur les effets indésirables des médicaments radiopharmaceutiques Thérapie 51 550-553
[4]
Bagheri H(1998)Prevalence of adverse reactions to positron emitting radiopharmaceuticals in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine J Nucl Med 39 2190-2192
[5]
Galian ME(1996)Prevalence of adverse reactions in nuclear medicine: Pharmacopeia Committee of the Society of Nuclear Medicine J Nucl Med 37 185-192
[6]
Bastie D(2019)Adverse events of diagnostic radiopharmaceuticals: a systematic review Sem Nucl Med 49 382-410
[7]
Silberstein EB(2006)Under-reporting of adverse drug reactions: a systematic review Drug Saf 29 385-396
[8]
Silberstein EB(2018)Adverse reactions to radiopharmaceuticals: a survey based on clinical cases using criteria of systematic review Ther Innov Regul Sci 52 109-113
[9]
Ryan J(2011)Pitfalls with radiopharmaceuticals Am J Med Sci. 342 50-53
[10]
Schreuder N(2015)Adverse drug reaction reports of patients and healthcare professionals-differences in reported information Pharmacoepidemiol Drug Saf 24 152-158